HomeKLRS • NASDAQ
add
Kalaris Therapeutics Inc
Previous close
$6.90
Day range
$6.26 - $7.00
Year range
$5.90 - $24.15
Market cap
117.26M USD
Avg Volume
49.79K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
CNBC
53 minutes ago
S&P 500 stock futures rise after Microsoft, Meta post earnings beats: Live updates
3.38%
CNN
6 hours ago
S&P 500, Dow close out April in the red as economy contracts for first time since 2022
0.15%
0.35%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.13M | 105.92% |
Net income | -22.03M | -534.57% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.64M | -48.28% |
Total assets | 6.16M | 84.88% |
Total liabilities | 56.78M | 1,340.36% |
Total equity | -50.62M | — |
Shares outstanding | 18.70M | — |
Price to book | -0.48 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -22.03M | -534.57% |
Cash from operations | -7.85M | -89.82% |
Cash from investing | — | — |
Cash from financing | 7.58M | 10.47% |
Net change in cash | -274.00K | -110.06% |
Free cash flow | — | — |
About
Founded
2019
Headquarters
Website
Employees
14
